Drug Enforcement D-105-2013

Lack of Assurance of Sterility; container closure issues with the bulk batch.

Status

Terminated

Classification

Class II

Report Date

January 2, 2013

Termination Date

August 29, 2013

Product Information

Product description
Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom
Product quantity
42010 vials
Reason for recall
Lack of Assurance of Sterility; container closure issues with the bulk batch.
Recall initiation reason
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.

Location & Firm

Recalling firm
F. Hoffmann-LaRoche Ltd.
Address
Grenzacherstrasse 124, N/A

Switzerland
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-105-2013
Event ID
63656
Recall initiation date
September 5, 2012
Center classification date
December 21, 2012
Code info
bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12
More code info